Gizem Yeğen

Gizem Yeğen

Auto-generated profile, based on publicly available information

Gizem Yeğen

Istanbul University - Cerrahpasa

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in ACS Omega
Verified
Journal Article
Open access
MEMeliha Ekinci
Meliha Ekinci
GYGizem Yeğen
Gizem Yeğen
BABuket Aksu
Buket Aksu
DIDerya İlem-Özdemir
Derya İlem-Özdemir
The aim of the study was to prepare and evaluate the potential use of poly(lactic acid)/poly(vinyl alcohol) (PLA/PVA) nanoparticle formulations as a drug delivery system. The nanoparticle formulations were successfully developed by the double emulsification/solvent evaporation method. The developed formulations were optimized using the quality by design approach of the ICH Q8 (Pharmaceutical Development) guideline. In the studies, the effects of emulsifying devices, evaporation technique, centrifugation effect, and polymer concentrations on the physicochemical parameters of the formulations were investigated to obtain the best results. Furthermore, the prepared formulations were evaluated for clarity, particle size, distribution, zeta potential, surface and morphological features, preparation efficiency, and long-term stability. Based on the obtained results, the nanoparticle formulation containing 12.5% PLA, 1% primer, and seconder PVA has a suitable particle size (181.7 ± 2.194 nm) and distribution (0.104 ± 0.049), zeta potential (-0.88 ± 0.45 mV), and high preparation efficiency (65.38%), and nanoparticles were spherical, had a smooth surface, and were stable up to 12 months. In conclusion, this novel formulation can be used as a potential drug delivery system.

26 November 2022 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
ECE ÖZCAN BÜLBÜLECE ÖZCAN BÜLBÜL
ECE ÖZCAN BÜLBÜL
HHHasan Ali Husseın
Hasan Ali Husseın
GYGizem Yeğen
Gizem Yeğen
MOMehmet Evren Okur
Mehmet Evren Okur
Neslihan Üstündağ OkurNeslihan Üstündağ Okur
Neslihan Üstündağ Okur
BABuket Aksu
Buket Aksu
This research aimed to develop patches for transdermal delivery of acemetacin, which can be used to treat rheumatic diseasesand to determine their potential use. Patches were successfully created by solvent casting method using hydroxypropyl methylcellulose, propylene glycol, polyethylene glycol 400, tween 80, and dimethyl sulfoxide. Prepared patches were found using the Design of Experiments (DoE) method within the Quality by Design (QbD) approach. F1-ACM with a thickness of 0.1 ± 0.0 cm, a weight of 43.33 ± 6.29 mg, pH of 4.99 ± 0.24, moisture content of 18.33 ± 2.98%, a tensile strength of 9.196 ± 0.441 Mpa, elongation at break of 28.722 ± 0.803% and drug content of 100% was chosen as ideal formulation. 89.7% of ACM from F1-ACM was released in 5 min. F1-ACM significantly (p < 0.05) increased the response latency to the thermal stimulus at 90th (3.071 ± 0.517) and 120th (3.87 ± 0.332) min in the hot plate test. In the tail-flick experiment, F1-ACM significantly (p < 0.05) increased the reaction delay against heat stimuli at 90th (3.016 ± 0.695), 120th (2.884 ± 0.851), and 180th (2.893 ± 0.932) min. F1-ACM patch significantly (p < 0.001) inhibited paw edema formation at 1, 2, 3, 4, and 5 h after induction of inflammation as compared to the control group. Therefore, this formulation can be employed more efficiently for rheumatic disease. GRAPHICAL ABSTRACT

1 November 2021
Verified
Conference Paper
Closed access
PDF file
FYFurkan Yuksel
Furkan Yuksel
GYGizem Yegen
Gizem Yegen
BABuket Aksu
Buket Aksu

1 January 2023 in AURUM Journal of Engineering Systems and Architecture
Verified
Journal Article
Open access
PDF file
GYGizem Yeğen
Gizem Yeğen
CSCagla Senel
Cagla Senel
SPSaadet Kevser Pabuccuoğlu
Saadet Kevser Pabuccuoğlu
BABuket Aksu
Buket Aksu
Pharmaceutical development and authorization stages have high requirements that increase labour and costs. Risks for product quality and process robustness also increase in parallel with complex practices existing in the pharmaceutical industry and emerging as a result of developments. Although it is challenging to eliminate parameters leading to increased risks, there is need to appropriately manage the risks likewise arrange decision making processes. Designing and optimizing formulation and production processes to deliver the predetermined product quality is known as Quality by Design (QbD) in pharmaceutical development. In terms of data and knowledge, QbD can be carried out using a variety of technologies in this process. Mathematical modelling is one of these tools allows for the quick formation of subject knowledge, which may subsequently be used in an independent or integrated manner and to produce Design of Experiments (DOE). Response surface method (RSM), Artificial Neural Network (ANN), Genetic Algorithm (GA) are some of the assistive technologies used in mathematical modelling that enables to enlighten the effect of formulation and process variables on product quality attributes. The use of advanced mathematical modelling techniques in formulation and process development has become widespread and it appears to be beneficial in different areas of pharmaceutical development.

1 November 2021 in ICERI Proceedings
Verified
Conference Paper
Closed access
PDF file
SASham Al Alsaid Ahmed
Sham Al Alsaid Ahmed
GYGizem Yegen
Gizem Yegen
BABuket Aksu
Buket Aksu
Information about the paper titled "THE IMPORTANCE OF SOCIAL AND EMOTIONAL SKILLS IN EDUCATION LIFE OF GENERATION Y" at IATED Digital Library